Product image of Curosurf (Poractant Alfa) supplied by GNH India

Curosurf

Active Ingredient:
Poractant Alfa
Origin:
EU

Curosurf (Poractant Alfa)

Curosurf (Poractant Alfa) is a surfactant replacement therapy used to treat respiratory distress in premature infants. This medication helps improve lung function and oxygenation.

Manufacturer / TM Owner

Chiesi Farmaceutici S.P.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Curosurf is primarily used to treat respiratory distress syndrome (RDS) in premature infants. This condition occurs when the lungs are not fully developed and lack sufficient surfactant, a substance that keeps the air sacs open. Curosurf works by replacing the missing surfactant, allowing the lungs to function more effectively. It is administered directly into the lungs via endotracheal tube, providing immediate relief and support for breathing.

Side Effects

  • Curosurf helps to reduce the surface tension in the lungs, which allows the air sacs to stay open and function properly. This can lead to improved oxygenation and reduced need for mechanical ventilation. The effects are typically observed shortly after administration, providing rapid relief for infants suffering from respiratory distress.

Precautions & Warnings

  • Curosurf should be administered by healthcare professionals experienced in neonatal intensive care. It is important to follow proper handling and storage guidelines to maintain the efficacy of the medication. Always consult a healthcare provider for specific instructions and precautions related to the use of Curosurf.

Avoid Interactions

  • Curosurf is generally well-tolerated, but interactions with other medications should be considered. It is important to inform your healthcare provider about any other medications or treatments the infant is receiving. Always follow the advice of a healthcare professional regarding the use of Curosurf in combination with other therapies.

Frequently Asked Questions

Curosurf is used to treat respiratory distress syndrome in premature infants by replacing the missing surfactant in their lungs.

Curosurf is administered directly into the lungs via an endotracheal tube by a healthcare professional.

Curosurf helps reduce surface tension in the lungs, allowing air sacs to stay open and function properly, leading to improved oxygenation.

Curosurf should be administered by healthcare professionals experienced in neonatal intensive care, and proper handling and storage guidelines should be followed.

Interactions with other medications should be considered, and it is important to inform your healthcare provider about any other treatments the infant is receiving.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Poractant Alfa

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT